Tag Archive for: Research and Development

Life Science Partner Builds Canary’s Research and Development Team

Canary Research and Development Team

­­Life Science Partner is pleased to announce the successful placements of Canary Medical’s Senior Research & Development team.

Canary Medical is an innovative MedTech company modernizing smart implants in the orthopedic, cardiovascular, and aesthetic markets. The company integrates a sensor and microprocessor system into FDA-cleared implantable medical devices to remotely gather biometric data and transmit it back to physicians via the cloud to give real-time insights about the performance and safety of these products.

Partnering with Canary at its very inception, Life Science Partner recruited Chief Technology Officer Jeff Gross, VP of Technology Development Mark Phelps, VP of Research and Development Peter Schiller, VP of Operations Balakrishnan Shankar, and Senior Director of Regulatory Affairs & Quality Assurance Nora York. In turn, we worked with these leaders to recruit their technical teams who have been superstars in the fields of electronics, medical devices, and cloud software. These 7 talented, senior R&D engineers will help propel the company’s platform in telemedicine and medical devices.

The recruitment of Lan Herrington as Senior Quality Manager, Luis Dogue as Manager of Data Software, Kevin Gemmell as Senior Biomedical Engineer, David Mejia as Senior Manufacturing Engineer, Matthew Sturtevant as Senior Electromechanical Engineer, Ryan Peck as Senior Quality Engineer, and Reghu Rajan, MBA as Senior Systems Engineer will drive Canary Medical toward commercialization while pursuing their technology’s vast array of potential applications beyond the orthopedic space. They each bring to the company a track record of success and a combined expertise in the orthopedic and cardiovascular space with a broad range of experience from the medical device, healthcare, and information technology industries.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

/0 Comments/by

Peter Schiller, PhD Joins Canary Medical as Vice President, Research & Development

Life Science Partner Executive Search is pleased to announce the recruitment of Peter Schiller, PhD to Canary Medical, where he will serve as Vice President of Research and Development.

Canary Medical is an innovative medical technology company commercializing smart implants in the orthopedic, cardiovascular, and aesthetic markets.

The company integrates a sensor and microprocessor system into FDA-cleared implantable medical devices to generate real-time insights about the performance and safety of these products.

Peter Schiller, PhD

In his new role, Schiller will spearhead continued product development and commercialization, provide scientific and strategic leadership for this growing team, and serve as the face of the research and development organization to internal and external audiences.

An engineer with a PhD focused on smart sensor systems, Schiller has spent 20 years developing and commercializing novel medical technologies, including a MEMS sensor company he founded and led as CEO.

Schiller previously served as Director of Device Development at San Diego-based Progenity, where he led the design and development of a combination device and connected drug delivery system for gastrointestinal health.

“Peter has well-demonstrated his ability to design and develop novel, forward-thinking electromechanical solutions to complex medical problems,” notes Tom Callaway, Founder and President of Life Science Partner. “His decades in young companies speaks to his entrepreneurial spirit, risk tolerance, and real-world education in the challenges facing implantable medical device startups and how to best navigate them.”

Schiller earned his PhD in Electrical engineering from the University of Minnesota – Twin Cities, and his Masters and Bachelors degrees in Electrical Engineering from the same.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Mark Adler Joins Medtronic Diabetes as Director, Research and Development, Sensors Engineering

Life Science Partner recruits former Vice President of Manufacturing and Manufacturing Engineering at GluMetrics

Life Science Partner announces the recruitment of Mark Adler to become Director, Research and Development, Sensors Engineering for Medtronic Diabetes.

Medtronic Diabetes is the world leader in insulin pump therapy and continuous glucose monitoring.

In his most recent role at GluMetrics, Adler was responsible for building the intensive care unit glucose sensor product portfolio for the emerging medical device company.  He has a broad background in breakthrough device development in many different platforms – including coating vascular stents at Devax and creating a new sensor platform at DexCom as Senior Director of Manufacturing Operations and Engineering.  This new role is somewhat of a homecoming, as he was previously the Director of Advanced Engineering at Medtronic AVE.

Mark Adler

In his new role at Medtronic Diabetes, Adler will be responsible for determining and executing the overall strategic technology plan for the sensors development organization, as they help build the next-generation sensors and cutting edge continuous glucose monitoring solutions.

“Adler is a passionate, highly motivated engineering executive with an impressive background in sensor development for the diabetes market” noted Tom Callaway, MD, founder and president of Life Science Partner.  “He has broad management experience across all functions of a medical device organization and will bring leadership and quality execution to Medtronic Diabetes’ portfolio of continuous glucose monitoring solutions.”

Adler received his Bachelor of Technology Degree in Mechanical Engineering from the Rochester Institute of Technology and his Masters in Business Administration from Argosy University, Seattle.

Learn More About the Medical Device Industry
/0 Comments/by

Steve Walsh joins Carticept Medical as Vice President of Research and Development

Life Science Partner recruits biomaterials expert to lead synthetic cartilage product development

Life Science Partner announces the recruitment of Steve Walsh, PhD, a senior biomaterials technology and development expert, to Carticept Medical to become Vice President, Research and Development for the company. 

Carticept Medical is an Atlanta-based medical device company developing novel therapies designed to address the shortcomings of current conservative and surgical treatment options for patients with osteoarthritis or cartilage injuries.

In his previous role at Cyrolife, another Atlanta-based biotechnology company, Walsh was responsible for leading Biomaterials Technologies and Product Development for the company’s implantable biological devices, surgical adhesives and biomaterials for use in cardiac, vascular, general and reconstructive surgery.

Before his tenure at Cyrolife, Walsh served as Manager of the Implantable Device Development Engineering Group at BioControl Technology in Indiana, PA.   In his new role at Carticept, Walsh will have key responsibility for managing R&D efforts for the company’s synthetic cartilage products and the pipeline portfolio of novel therapeutic solutions.

“Walsh is a talented biomaterials scientist with a deep intellect and passion for his work,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His deep knowledge base and broad development and process abilities will greatly benefit the important clinical and commercial efforts at Carticept.”

Walsh earned his Bachelor of Science in Plastics Engineering at the University of Lowell in Lowell Massachusetts and his Masters and Doctor of Philosophy degrees in Macromolecular Science at Case Western Reserve University in Cleveland, Ohio.

/0 Comments/by

Mark Phelps to join LifeSync Corporation as Vice President of Research and Development

Life Science Partner announces recruitment of former Senior Director, Product Development and Technology at Medtronic, Inc.

Life Science Partner announces the appointment of Mark Phelps, a senior technology development leader, to LifeSync Corporation as the Vice President of Research and Development.

LifeSync is an early stage medical device company focused on the continued development, marketing and sales of the first wireless electrocardiogram (ECG) data communications system appropriate for hospital and outpatient settings.

In his most recent role at Medtronic, a global leader in the development of medical technology, Phelps managed the Electronic Systems Technology, New Therapies and Diagnostics Division of Medtronic’s Microelectronics Center in Tempe, Arizona.

His team’s contributions to technology development impacted the wide range of electrophysiology products including pacemakers and external defibrillators.  Well versed in medical device development, Phelps was previously Senior Manager of Tachyarrhythmia Product Development for the company.  Before joining Medtronic, Phelps managed Strategic Product Development for Motorola.

“Phelps is the prototype of a forward-thinking scientist and technology innovator,” noted Tom Callaway, President of Life Science Partner.  “He will be a visionary leader in building innovative technologies for LifeSync in its mission to enable the future of healthcare for improved patient outcomes.”

At LifeSync, Phelps will be focused on developing a world-class engineering team building the next-generation biological data sensors, transmission devices and integrated systems.   He will serve as senior technical advisor and provide insight on how the technology can serve customer needs and direction in expanding the company’s platform.

Phelps earned his Bachelor of Science and Master of Electrical Engineering from Florida Institute of Technology (FIT) in Melbourne, Florida.  He received a PhD in Electrical Engineering from FIT as well.

/0 Comments/by

Sam Helgerson to join Symphony Medical, Inc. as Vice President, Research and Development

Life Science Partner recruits former Senior Research Director of Bioscience Research & Development at Baxter Healthcare Corporation.

Life Science Partner announces the recruitment of Sam Helgerson, a senior product development leader, to Symphony Medical, Inc. as the Vice President, Research and Development.

Symphony Medical is a venture-backed development stage company focused on non-destructive therapies directed toward the treatment of cardiac abnormalities. The Company is currently developing a number of novel technologies including a non-surgical, non-ablative biological therapy for the treatment of post-operative atrial fibrillation, a therapy for congestive heart failure that utilizes unique biomaterials to effect cardiac reconstruction and reversal of cardiac remodeling and a cell-based biologic therapy for the treatment of chronic atrial fibrillation.

In Helgerson’s most recent role at Baxter Healthcare, a global manufacturing company that develops medical devices, pharmaceuticals and biotechnology products for the healthcare industry, he was responsible for leading the R&D efforts focused on developing biotherapeutic products for tissue regeneration, especially to promote angiogenesis and neovascularization in both wound healing and bone regeneration applications.  Prior to his numerous leadership roles at Baxter, Helgerson held academic research positions at the University of California and Montana State University.

“Sam has extensive leadership experience in biopharmaceutical product development and a drive and enthusiasm to successfully take products from early-stage discovery through to commercialization,” noted Tom Callaway, MD, founder and president of Life Science Partner.

Helgerson will have the responsibility of providing scientific intelligence and leading the decision process regarding the potential clinical utility, product definition and development, and regulatory strategy of products within the product pipeline.

Helgerson received his Bachelor of Science degree from University of Puget Sound in Tacoma, Washington and his Doctorate degree in Biophysics from Purdue University in West Lafayette, Indiana.  He completed his postdoctoral fellowship at the Cardiovascular Research institute at the University of California in San Francisco.

/0 Comments/by

David Enscore to Direct Product Research and Development at Altea Therapeutics

Life Science Partner placement brings a record of innovation to Atlanta-based company

Life Science Partner announces the placement of Dr. David J. Enscore as senior vice president, product research and development with Altea Therapeutics in Atlanta. As an integral part of Altea’s executive leadership, the 20-year industry veteran will direct pharmaceutical and clinical product development while playing an important role in identifying and pursuing strategy. Altea Therapeutics works with the pharmaceutical and biotechnology industries to develop alternatives for medicine and vaccine delivery.

“When we introduced David to Altea, he was very impressed with the company and its microporation technology,” says Life Science Partner Founder and President Thomas H. Callaway. “Because there are so few candidates with David’s qualifications and his unique background suits Altea’s needs perfectly, this is an exceptional placement.”

Enscore comes from Spherics, a Rhode Island-based early phase drug delivery company using bioadhesive polymers and nanoencapsulation to improve the oral bioavailability of therapeutic agents. As vice president of R&D there, he was responsible for all scientific and technical operations the from the company’s inception. Later, Enscore assumed general management responsibilities as well. With Focal, Inc., a medical device company commercializing resorbable surgical sealants and drug delivery platform polymers, he served as vice president and guided all materials-related activities, including all research and development activities related to Focal’s core polymer technologies. During a 16-year career at ALZA Corporation, where he began his career as a chemical engineer, Enscore held the titles of executive director, transdermal product development; director, new product discovery; director, physical sciences; and others. At ALZA, he managed the development of four controlled release pharmaceuticals including the NicoDerm CQ patch. Enscore is an inventor on 24 U.S. patents in drug delivery and medical devices.

Enscore earned both his doctorate in chemical engineering (with a minor in polymer science) and his bachelor’s in chemical engineering at North Carolina State University.

/0 Comments/by